Cardiovascular Systems Inc. (CSII) announced Monday that it presented 30-day data from its ORBIT II study of severely calcified coronary lesions at the 2013 American College of Cardiology conference in San Francisco. The results demonstrated that CSI's technology produced clinical outcomes that exceeded the trial's two primary endpoints by a significant margin.
Cardiovascular Systems has been rising since the open of trade Monday and is now up 1.40 at $17.90. The stock has climbed above a month and a half long range and has set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.